Lorenz Lehmann
Has grant
Head of Cardio-Oncology Unit
GermanyResearch Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Dr. Lorenz Lehmann is the Head of the Cardio-Oncology Unit at the University Hospital of Heidelberg, Germany. His research focuses on cancer-related immune therapies, risk prediction in heart failure, and the interactions between heart conditions and tumors. Recent publications include studies on immune checkpoint inhibitor-associated myocarditis and the endothelial activation and stress index (EASIX) in cardiovascular disease.
Recent Grants
Grant: Open
Nr4a1 (nuklearer rezeptor 4a1) als therapeutischer Regulator des kardialen Stoffwechsels bei Herzversagen
Open Date: 2025-04-01
Close Date: 2027-03-01
Grant: Close
Cardiomyocyte-specific endogenous transcriptional restoration of KLF15 by nuclease-dead Cas9 as a novel therapeutic concept in heart failure
Open Date: 2023-04-01
Close Date: 2024-11-01
Grant: Close
Identification and characterization of enhancers in cardiac remodeling
Open Date: 2023-04-01
Close Date: 2024-09-01
Grant: Close
Uncovering cardioprotective strategies by transcriptional profiling of immune checkpoint inhibitor-associated myocarditis (ICIM)
Open Date: 2022-04-01
Close Date: 2023-03-01
Grant: Close
IVOLDAMT-HF - In vivo Validierung der L-2-Hydroxyglutarat Dehydrogenase als neue metabolische Zielstruktur bei Herzinsuffizienz, Studienteil Heidelberg incl. Monitoring
Open Date: 2021-02-01
Close Date: 2023-12-31
Articles (10)
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2024
Year:
2024
Year:
2024
Collaborators (2)
Sean Wu
Associate Professor of Medicine
Stanford University School of Medicine
Nicolas Palaskas
Assistant Professor
The University of Texas MD Anderson Cancer Center
ApplyKite TwinLearns as you applyMake your next move.
Prepare your application
Review drafts before you send them.